|Mr. Thomas M. Patton J.D.||Chief Exec. Officer, Pres and Director||502.28k||N/A||53|
|Mr. Jeffery A. Baird||Chief Financial Officer and Sec.||311.25k||N/A||63|
|Mr. John K. Gamelin Ph.D.||VP of R&D||278.86k||N/A||52|
|Dr. Paul B. Benni Ph.D.||Chief Scientific Officer||N/A||N/A||49|
|Susan Carron||Director of Corp. Communications||N/A||N/A||N/A|
CAS Medical Systems, Inc., a medical technology company, develops, manufactures, and markets non-invasive patient monitoring products worldwide. The company provides FORE-SIGHT tissue oximeter monitors, sensors, and accessories, as well as offers FORE-SIGHT ELITE monitors; and traditional monitoring products, such as non-invasive blood pressure measurement technologies under the MAXNIBP and MAXIQ brand names, as well as provides monitor service and repair. It markets products through its own sales force, distributors, manufacturers representatives, and original equipment manufacturers, as well as through hospital, surgery center and outpatient facility, homecare, veterinary, and emergency medical distribution channels. CAS Medical Systems, Inc. was incorporated in 1984 and is headquartered in Branford, Connecticut.
CAS Medical Systems, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.